Re-reviewed and repaired `doi__10.3389_fmicb.2017.00544`.

I added [repair_doi_10_3389_fmicb_2017_00544_worker246.py](/root/work/抗菌肽/数据库/batch/4-team/scripts/repair_doi_10_3389_fmicb_2017_00544_worker246.py) and used it to update the owned worker-2/4/6 artifacts. The key repair was correcting Table 2 activity orientation from `entity=MIC` to the actual peptides, recovering Table 3 hemolysis rows, and rewriting database adjudication so table-backed rows are `source_verified` while exact figure-derived antibiofilm database values remain explicit `source_conflict` cautions.

Final state:
- `final/review_report.json`: `accepted_with_cautions`, `publication_grade: true`
- `quality_feedback.json`: `issue_count: 0`, no rework targets
- `workflow_context.json`: `open_rework_tickets: []`
- Activity rows: `12`
- Database rows: `29 source_verified`, `18 source_conflict`
- Mechanism claims: `3`, bounded and non-overclaiming

Validation passed:
- Semantic gate: `publication_grade_pass_count=1`, `fail_count=0`
- Publication gate: `publication_grade_pass=true`, `risk_counts={}`
- JSON parse checks passed for repaired packet/final/work artifacts
- Repair script `py_compile` passed

No `unrecoverable_material_gaps` were needed because the active blocker was recoverable from local XML/PDF/database material. The remaining limitations are nonblocking cautions recorded in the review report.

